Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Die Anaesthesiologie
|
May 16, 2024
German guidelines for airway management 2023
Tim Piepho, M Kriege, C Byhahn, et al.
Familial Cancer
|
October 24, 2003
MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC)
M Kriege, C T Brekelmans, C Boetes, et al.
Nature Communications
|
March 25, 2023
Lacking mechanistic disease definitions and corresponding association data hamper progress in network medicine and beyond
Sepideh Sadegh, James Skelton, Elisa Anastasi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2011
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
P M L H Vencken, M Kriege, D Hoogwerf, et al.
British Journal of Cancer
|
June 12, 2014
Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy
M Kriege, A Hollestelle, A Jager, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2005
Survival and prognostic factors in BRCA1-associated breast cancer
C T M Brekelmans, C Seynaeve, M Menke-Pluymers, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2007
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases
C T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, et al.
Familial Cancer
|
February 22, 2015
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study
M R Wevers, M K Schmidt, E G Engelhardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2013
Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands
P M L H Vencken, W Reitsma, M Kriege, et al.
Breast Cancer Research and Treatment
|
October 20, 2006
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer
M Kriege, C T M Brekelmans, H Peterse, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Die Anaesthesiologie
|
May 16, 2024
German guidelines for airway management 2023
Tim Piepho, M Kriege, C Byhahn, et al.
Familial Cancer
|
October 24, 2003
MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC)
M Kriege, C T Brekelmans, C Boetes, et al.
Nature Communications
|
March 25, 2023
Lacking mechanistic disease definitions and corresponding association data hamper progress in network medicine and beyond
Sepideh Sadegh, James Skelton, Elisa Anastasi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2011
Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients
P M L H Vencken, M Kriege, D Hoogwerf, et al.
British Journal of Cancer
|
June 12, 2014
Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy
M Kriege, A Hollestelle, A Jager, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 2005
Survival and prognostic factors in BRCA1-associated breast cancer
C T M Brekelmans, C Seynaeve, M Menke-Pluymers, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2007
Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases
C T M Brekelmans, M M A Tilanus-Linthorst, C Seynaeve, et al.
Familial Cancer
|
February 22, 2015
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study
M R Wevers, M K Schmidt, E G Engelhardt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 2, 2013
Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands
P M L H Vencken, W Reitsma, M Kriege, et al.
Breast Cancer Research and Treatment
|
October 20, 2006
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer
M Kriege, C T M Brekelmans, H Peterse, et al.
Page
of 3